Bypass kinase pathways lead to acquired CDK4/6 inhibitor resistance in prostate cancer.
Renee de Leeuw,Christopher M. McNair,Matthew J. Schiewer,Neermala P. Neupane,Michael A. Augello,Zhen Li,Larry Cheng,Akihiro Yoshida,J. Alan Diehl,E. Starr Hazard,Sean M. McCourtney,Gary Hardiman,Maha H. Hussain,Justin M. Drake,Wm. Kevin Kelly,Karen E. Knudsen CANCER RESEARCH(2018)
AI 理解论文
溯源树
样例